BioSpace News Archive

Global partnership will fund the development of promising new antibacterial products and diagnostics.

Ampio Pharmaceuticals, Inc. announced their 2017 financial results during a conference call hosted on Wednesday, March 7th at 5:00 pm EST. Included below are highlighted disclosures from the corporate update and filed Annual report on Form 10K.

Tetra Discovery Partners Inc. announced that the U.S. Food and Drug Administration has accepted the Investigational New Drug Application (IND) for BPN14770.

The Society for Brain Mapping and Therapeutics (SBMT) officially announced today they will hold their 15th Annual World Congress at the Millennium Biltmore Hotel in DTLA from April 13-15, 2018.

Congressional Candidate to Hear Concerns of Industry Leaders in Health Care Innovations

Organogenesis Inc., a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets, today announced its PuraPly® Antimicrobial (AM) wound management product is now available in a new, easy-to-use 1.6 cm disc size.

Symic Bio, a biopharmaceutical company developing novel extracellular matrix targeting drugs, today announced that Ken Horne, Chief Executive Officer, will present an overview of the company pipeline at the BioCentury 25th Annual Future Leaders in the Biotech Industry Conference in New York.

Patients showed significant improvements in cognitive function, levels of fatigue and ability to perform daily tasks

The U.S. Food and Drug Administration today formally requested public input on its proposal to reduce nicotine in cigarettes to minimally or non-addictive levels.

Industry leader in Ketamine Infusion Therapy opens second South Florida facility to meet growing demand for effective solutions to treat mental health conditions.